1. Home
  2. NVTS vs ABCL Comparison

NVTS vs ABCL Comparison

Compare NVTS & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • ABCL
  • Stock Information
  • Founded
  • NVTS 2014
  • ABCL 2012
  • Country
  • NVTS United States
  • ABCL Canada
  • Employees
  • NVTS N/A
  • ABCL N/A
  • Industry
  • NVTS Semiconductors
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVTS Technology
  • ABCL Health Care
  • Exchange
  • NVTS Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • NVTS 762.1M
  • ABCL 895.0M
  • IPO Year
  • NVTS N/A
  • ABCL 2020
  • Fundamental
  • Price
  • NVTS $3.50
  • ABCL $2.80
  • Analyst Decision
  • NVTS Buy
  • ABCL Buy
  • Analyst Count
  • NVTS 8
  • ABCL 3
  • Target Price
  • NVTS $4.75
  • ABCL $8.50
  • AVG Volume (30 Days)
  • NVTS 8.2M
  • ABCL 2.4M
  • Earning Date
  • NVTS 11-04-2024
  • ABCL 11-04-2024
  • Dividend Yield
  • NVTS N/A
  • ABCL N/A
  • EPS Growth
  • NVTS N/A
  • ABCL N/A
  • EPS
  • NVTS N/A
  • ABCL N/A
  • Revenue
  • NVTS $91,381,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • NVTS $8.34
  • ABCL N/A
  • Revenue Next Year
  • NVTS $5.50
  • ABCL $36.56
  • P/E Ratio
  • NVTS N/A
  • ABCL N/A
  • Revenue Growth
  • NVTS 38.99
  • ABCL N/A
  • 52 Week Low
  • NVTS $1.75
  • ABCL $2.34
  • 52 Week High
  • NVTS $8.44
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 53.60
  • ABCL 44.26
  • Support Level
  • NVTS $3.10
  • ABCL $2.76
  • Resistance Level
  • NVTS $4.66
  • ABCL $3.05
  • Average True Range (ATR)
  • NVTS 0.47
  • ABCL 0.16
  • MACD
  • NVTS -0.04
  • ABCL -0.03
  • Stochastic Oscillator
  • NVTS 35.62
  • ABCL 0.00

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: